Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, Without Compromising the Quality of Colonoscopy? An International Multi-centre Randomized Controlled Trial.

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorChinese University of Hong Kong

About this trial

The goal of this study is to assess the clinical and cost-effectiveness of the AI bowel preparation evaluation system in reducing the consumption volume of the standard high-volume PEG regimen before colonoscopy among the older population.

Researchers will compare bowel preparation adequacy and other colonoscopy quality matrices, and patient satisfaction between patients using the AI system and those using Standard Practice.

Eligibility criteria

Qualifiers

individual aged 65 years or above

undergoing colonoscopy for any indication

requiring a standard high-volume PEG regimen for bowel preparation

having a smartphone themselves or their caregivers (including ward nurses) having one will be recruited.

Disqualifiers

allergy to PEG,

suspected or diagnosed gastrointestinal obstruction or perforation,

suspected or diagnosed ileus

suspected or diagnosed gastric retention

Trial design

Treatments tested in this trial

  • AI

Treatment groups

1,824 Participants
are divided into 2 treatment groups